Clinical Trial Update: Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study evaluating donor white blood cell infusions with interleukin-2 in patients undergoing autologous stem ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Donor white blood cell infusion
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | Phase 1, Phase 2 | Status: COMPLETED